Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine
NCT ID: NCT07147205
Last Updated: 2025-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
72 participants
INTERVENTIONAL
2026-02-05
2029-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Meaning-Centered Psychotherapy in Advanced Cancer
NCT00067288
Group Meaning-Centered Psychotherapy for the Improvement of Wellbeing in Caregivers of Patients With Advanced Cancer
NCT06630351
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
NCT07225309
A Study of Meaning-Centered Psychotherapy for Caregivers to People With Cancer
NCT06307535
A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers
NCT06172907
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objectives are to describe the characteristics and outcomes of participants who attend at least one session of MCGP:
1. Describe demographic, clinical characteristics, reasons for referral, and IMC utilization data for participants who attend MCGP.
2. Examine anxiety, depression, quality of life, meaning in life, and fear of cancer recurrence before and after participation in MCGP.
3. Describe satisfaction and qualitative feedback from group participants, including perceived effectiveness and outcomes, experiences participating in the group virtually, and reactions to specific elements of the therapy modified for cancer survivors, length of group (90 minutes), and the nature of a closed group within the IMC.
Secondary Objectives
4. Examine whether demographic, clinical, or symptoms-based (pre) measures are associated with number of MCGP sessions attended.
5. Examine whether number of sessions attended is associated with change in outcome measures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention with Meaning-Centered Group Psychotherapy
Therapy
MCGP will be delivered in 8 weekly sessions for 90 minutes over Zoom by a licensed doctoral level psychologist.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Therapy
MCGP will be delivered in 8 weekly sessions for 90 minutes over Zoom by a licensed doctoral level psychologist.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
2. Pregnant women will not be enrolled in this study.
3. Cognitively impaired subjects will not be enrolled in this study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth C Conti, MD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2025-06343
Identifier Type: OTHER
Identifier Source: secondary_id
2025-0994
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.